Junichi Kiyasu
Iizuka, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Epcoritamab plus gemcitabine and oxaliplatin in transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma: how should this regimen be positioned in current treatment algorithms?
Journal: Translational cancer research
Published: March 02, 2026
Fibrin-associated large B-cell lymphoma arising in benign gynecologic tumors: insights into disease spectrum expansion and pathophysiology.
Journal: Virchows Archiv : an international journal of pathology
Published: December 24, 2025
Frequency of exercise and cancer-related fatigue among patients with lymphoma.
Journal: BJC reports
Published: November 23, 2025
Efficacy and Safety of Rituximab plus Modified EPOCH (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Transplant-ineligible Relapsed/Refractory Diffuse Large B-cell Lymphoma.
Journal: Internal medicine (Tokyo, Japan)
Published: April 13, 2025
Machine Learning Model to Guide Empirical Antimicrobial Therapy in Febrile Neutropenic Patients With Hematologic Malignancies.
Journal: Anticancer research
Published: April 09, 2025
Lymphomatosis cerebri caused by adult T cell leukemia/lymphoma: a differential diagnosis for depression: a case report.
Journal: Journal of medical case reports
Published: March 06, 2024
Efficacy and Safety of the Modified EPOCH Regimen (Etoposide, Vincristine, Doxorubicin, Carboplatin, and Prednisolone) for Adult T-cell Leukemia/Lymphoma: A Multicenter Retrospective Study.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 26, 2020
Fatal Disseminated Tuberculosis during Treatment with Ruxolitinib Plus Prednisolone in a Patient with Primary Myelofibrosis: A Case Report and Review of the Literature.
Journal: Internal medicine (Tokyo, Japan)
Published: December 28, 2017
Clinicopathological analysis of polyploid diffuse large B-cell lymphoma.
Journal: PloS one
Published: December 07, 2017
Methotrexate-associated lymphoproliferative disorders with angioimmunoblastic T-cell lymphoma-like features accompanied by gamma-heavy chain disease in a patient with rheumatoid arthritis.
Journal: Pathology international
Published: September 21, 2017
Expression of programmed death ligand 1 is associated with poor prognosis in myeloid sarcoma patients.
Journal: Hematological oncology
Published: August 07, 2017
Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.
Journal: European journal of haematology
Published: January 22, 2017
Last Updated: 09/26/2026